Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

United Kingdom's National Health Service begins a mass vaccination campaign against COVID-19 using the BNT162b2 vaccine developed by BioNTech and Pfizer.

The United Kingdom's National Health Service begins a mass vaccination campaign against COVID-19 using the BNT162b2 vaccine developed by BioNTech and Pfizer. Seniors over the age of 80 and certain healthcare workers will be among the first to receive the vaccine.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthUnited Kingdom's National Health Service begins a mass vaccination campaign against COVID-19 using the BNT162b2 vaccine developed by BioNTech and Pfizer.

The United Kingdom's National Health Service begins a mass vaccination campaign against COVID-19 using the BNT162b2 vaccine developed by BioNTech and Pfizer. Seniors over the age of 80 and certain healthcare workers will be among the first to receive the vaccine.

View Premium plansBrowse free archive reports